Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy

Documenti analoghi

• Predictors for choosing doravirine‐based versus INSTI‐based regimen in ART‐naïve and ART‐experienced people with HIV in real‐world setting: Data from the Icona cohort
  di: Antonella d'Arminio Monforte, et al.
  Pubblicazione: (2024)
• Predictors of discontinuing injectable cabotegravir/rilpivirine and virologic outcomes after resuming oral antiretroviral therapy
  di: Tali Faggiano, et al.
  Pubblicazione: (2025)
• On the possibility of superradiant neutrino emission by atomic condensates
  di: Blasone, Massimo, et al.
  Pubblicazione: (2025)
• Implementing the National Vaccination Plan in people with HIV in Italy : A survey among ICONA centres
  di: Antonio Russo, et al.
  Pubblicazione: (2026)
• Regaining virological suppression in a woman living with a six‐class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests
  di: Bianca Monti, et al.
  Pubblicazione: (2024)